We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
76
Lantheus
LNTH
$6.59B
$15.2M 0.08%
+184,000
New +$11.9M
AJRD
77
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$15.2M 0.08%
+270,000
New +$15.1M
AAC
78
DELISTED
Ares Acquisition Corporation
AAC
$14.7M 0.08%
1,425,000
AVTR icon
79
Avantor
AVTR
$9.19B
$14.4M 0.08%
681,418
+152,954
+29% +$3.49M
FWAC
80
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$13.9M 0.08%
1,360,040
TCVA
81
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$12.4M 0.07%
1,211,459
ISEE
82
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$11.8M 0.06%
484,799
-977,201
-67% -$21.4M
BRMK
83
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$11.5M 0.06%
2,437,995
-2,412,005
-50% -$10.7M
YTPG
84
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$11.1M 0.06%
1,116,833
COGT icon
85
Cogent Biosciences
COGT
$7.24B
$10.6M 0.06%
983,452
+898,313
+1,055% +$11.5M
BHVN icon
86
Biohaven
BHVN
$2.21B
$10.2M 0.06%
750,000
-250,000
-25% -$3.98M
SCRM
87
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.2M 0.06%
1,000,000
CVII
88
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$10.1M 0.06%
1,000,000
CCVI
89
DELISTED
Churchill Capital Corp VI
CCVI
$10.1M 0.06%
997,767
TVRD
90
Tvardi Therapeutics
TVRD
$23.4M
$9.8M 0.05%
55,427
-2,190
-4% -$733K
NETC
91
DELISTED
Nabors Energy Transition Corp.
NETC
$9.45M 0.05%
900,000
RIO icon
92
Rio Tinto
RIO
$164B
$9.43M 0.05%
+137,500
New +$9.98M
PSPC
93
DELISTED
Post Holdings Partnering Corporation
PSPC
$8.58M 0.05%
848,184
KCGI
94
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$8.08M 0.04%
775,200
APGB
95
DELISTED
Apollo Strategic Growth Capital II
APGB
$7.69M 0.04%
750,000
PANA
96
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.65M 0.04%
750,000
ARYE
97
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$7.62M 0.04%
745,000
CORS
98
DELISTED
Corsair Partnering Corporation
CORS
$7.18M 0.04%
700,000
KVSA
99
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$7.1M 0.04%
700,000
ALVO icon
100
Alvotech
ALVO
$1.29B
$6.45M 0.04%
500,000

Similar funds

Farallon Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Farallon Capital Management held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in UnitedHealth worth $409M.

  • Farallon Capital Management's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Farallon Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Farallon Capital Management fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Farallon Capital Management opened 14 new positions and closed 63 in Q1 2023.
  • Farallon Capital Management's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.